These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2340080)
1. Effects of conformational constraint in 2- and 8-cycloleucine analogues of oxytocin and [1-penicillamine] oxytocin examined by circular dichroism and bioassay. Fric I; Hlavacek J; Rockway TW; Chan WY; Hruby VJ J Protein Chem; 1990 Feb; 9(1):9-15. PubMed ID: 2340080 [TBL] [Abstract][Full Text] [Related]
2. Pharmacological, conformational and dynamic properties of cycloleucine-2 analogues of oxytocin and [1-penicillamine]oxytocin. Hruby VJ; Rockway TW; Viswanatha V; Chan WY Int J Pept Protein Res; 1983 Jan; 21(1):24-34. PubMed ID: 6826279 [TBL] [Abstract][Full Text] [Related]
3. Conformational comparisons of oxytocin agonists, partial agonists, and antagonists using laser Raman and circular dichroism spectroscopy. Examination of 1-penicillamine and diastereoisomeric analogues. Hruby VJ; Mosberg HI; Fox JW; Tu AT J Biol Chem; 1982 May; 257(9):4916-24. PubMed ID: 7068672 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, pharmacological, conformational, and dynamic studies of the potent hormone antagonists [1-penicillamine, 4-threonine]-oxytocin and [1-penicillamine, 2-phenylalanine, 4-threonine]-oxytocin. Conformational and dynamic considerations in the design of antagonists. Hruby VJ; Mosberg HI; Hadley ME; Chan WY; Powell AM Int J Pept Protein Res; 1980 Nov; 16(5):372-81. PubMed ID: 7216613 [TBL] [Abstract][Full Text] [Related]
5. Conformationally biased analogs of oxytocin. Lebl M; Toth G; Slaninová J; Hruby VJ Int J Pept Protein Res; 1992 Aug; 40(2):148-51. PubMed ID: 1446971 [TBL] [Abstract][Full Text] [Related]
6. The influence of steric interactions on the conformation and biology of oxytocin. Synthesis and analysis of penicillamine(6)-oxytocin and penicillamine(6)-5-tert-butylproline(7)-oxytocin analogs. Bélec L; Maletinska L; Slaninová J; Lubell WD J Pept Res; 2001 Sep; 58(3):263-73. PubMed ID: 11576333 [TBL] [Abstract][Full Text] [Related]
7. Conformational studies of oxytocin analogues with different ring sizes. I. Circular dichroism. Kawano K; Kobayashi Y; Kyogoku Y; Morikawa T; Sakakibara S Biochim Biophys Acta; 1979 May; 578(1):87-95. PubMed ID: 36924 [TBL] [Abstract][Full Text] [Related]
8. Conformation-activity studies of oxytocin. Effects of structural modifications at corner positions of the beta-turns on the uterotonic activity. Smith CW; Botos CR; Skala G; Walter R J Med Chem; 1977 Nov; 20(11):1457-60. PubMed ID: 915905 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and some pharmacological properties of [4-threonine,7-sarcosine]oxytocin, a peptide with high oxytocic potency, and of [4-threonine,7-N-methylalanine]oxytocin. Grzonka Z; Lammek B; Gazis D; Schwartz IL J Med Chem; 1983 Dec; 26(12):1786-7. PubMed ID: 6685771 [TBL] [Abstract][Full Text] [Related]
10. Importance of the third amino acid residue of oxytocin for its action on isolated rat uterus: study of relationship between hormone conformation and activity. Walter R; Smith CW; Roy J Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3054-8. PubMed ID: 184456 [TBL] [Abstract][Full Text] [Related]
11. Conformational study of the potent peptide hormone antagonist [1-penicillamine,2-leucine]oxytocin in aqueous solution. Mosberg HI; Hruby VJ; Meraldi JP Biochemistry; 1981 May; 20(10):2822-8. PubMed ID: 7248250 [TBL] [Abstract][Full Text] [Related]
12. Conformationally restricted analogs of oxytocin; stabilization of inhibitory conformation. Lebl M; Hill P; Kazmierski W; Kárászová L; Slaninová J; Fric I; Hruby VJ Int J Pept Protein Res; 1990 Oct; 36(4):321-30. PubMed ID: 2079387 [TBL] [Abstract][Full Text] [Related]
13. Failure of 1-L-penicillamine-oxytocin and 1-deaminopenicillamine-oxytocin to inhibit the uterine effect of oxytocin in rabbits in vivo. Fuchs AR; Lopes AC Endocrinology; 1970 Jan; 86(1):71-6. PubMed ID: 5409455 [No Abstract] [Full Text] [Related]
14. Analogues of a potent oxytocin antagonist with truncated C-terminus or shorter amino acid side chain of the basic amino acid at position 8. Flouret G; Chaloin O; Slaninová J J Pept Sci; 2003 Jun; 9(6):393-401. PubMed ID: 12846485 [TBL] [Abstract][Full Text] [Related]
15. Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones. Walter R; Smith CW; Roy J; Formento A J Med Chem; 1976 Jun; 19(6):822-5. PubMed ID: 985884 [TBL] [Abstract][Full Text] [Related]
16. Examination of structural characteristics of the potent oxytocin antagonists [dPen1,Pen6]-OT and [dPen1,Pen6, 5-tBuPro7]-OT by NMR, Raman, CD spectroscopy and molecular modeling. Bélec L; Blankenship JW; Lubell WD J Pept Sci; 2005 Jul; 11(7):365-78. PubMed ID: 15641022 [TBL] [Abstract][Full Text] [Related]
17. Some pharmacological actions of four synthetic analogues of oxytocin. BERDE B; DOEPFNER W; KONZETT H Br J Pharmacol Chemother; 1957 Jun; 12(2):209-14. PubMed ID: 13446374 [TBL] [Abstract][Full Text] [Related]
18. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1. Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and some pharmacological properties (4-beta-(2-thienyl)-L-alanine)oxytocin. Smith CW; Skala G; Walter R J Med Chem; 1978 Jan; 21(1):115-7. PubMed ID: 619140 [TBL] [Abstract][Full Text] [Related]
20. Relative conformational rigidity in oxytocin and (1-penicillamine)-oxytocin: a proposal for the relationship of conformational flexibility to peptide hormone agonism and antagonism. Meraldi JP; Hruby VJ; Brewster AI Proc Natl Acad Sci U S A; 1977 Apr; 74(4):1373-7. PubMed ID: 266179 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]